Skip to main content

Table 12 Fatty acid profile in rumen fluid and longissimus thoracis muscle of lambs fed CAL (Exp. 3)

From: Dietary Coleus amboinicus Lour. decreases ruminal methanogenesis and biohydrogenation, and improves meat quality and fatty acid composition in longissimus thoracis muscle of lambs

Fatty acid, % of total FA

Rumen fluid

LT muscle

CON

CAL

SEM

P value

CON

CAL

SEM

P-value

Saturated FA

 C8:0

0.03

0.01

0.01

0.39

1.44

0.60

0.39

0.31

 C10:0

0.08

0.49

0.14

0.16

1.85

1.49

0.41

0.68

 C12:0

0.64

0.98

0.13

0.19

1.62

1.23

0.26

0.48

 C13:0

1.87

1.94

0.17

0.86

1.09

0.82

0.26

0.63

 C14:0

1.11

1.29

0.14

0.56

1.77

1.62

0.26

0.79

 C15:0

1.46

1.44

0.13

0.92

1.13

1.11

0.22

0.96

 C16:0

16.5

18.7

0.49

0.01

14.1

12.5

0.50

0.11

 C17:0

0.73

0.62

0.07

0.48

0.87

1.07

0.13

0.48

 C18:0

47.3

40.9

1.59

0.03

15.4

12.1

0.73

0.01

 C20:0

0.06

0.06

0.02

0.86

0.21

0.20

0.04

0.88

 C21:0

0.05

0.11

0.02

0.17

0.26

0.38

0.07

0.41

 C22:0

0.11

0.08

0.02

0.37

0.52

0.65

0.08

0.44

 C23:0

0.09

0.21

0.03

0.02

0.34

0.71

0.11

0.10

 C24:0

0.56

0.55

0.03

0.87

0.18

0.50

0.09

0.09

Monounsaturated FA

 C14:1

0.24

0.28

0.06

0.76

0.69

0.96

0.17

0.45

 C15:1

1.11

0.87

0.12

0.32

1.57

1.49

0.20

0.84

 C16:1

0.31

0.32

0.05

0.96

1.03

0.99

0.14

0.89

 C17:1

0.17

0.17

0.05

0.99

1.24

1.71

0.18

0.20

 C18:1 trans-10

0.62

0.48

0.04

0.05

0.30

0.21

0.03

0.12

 C18:1 trans-11 (VA)

5.25

4.41

0.30

0.19

1.07

0.75

0.10

0.11

 C18:1 cis-9

6.98

7.53

0.37

0.49

22.1

22.4

1.11

0.92

 C18:1 cis-11

1.65

1.68

0.06

0.83

2.30

2.17

0.12

0.62

 C18:1 cis-12

0.57

0.68

0.06

0.46

0.77

0.62

0.08

0.37

 C18:1 cis-13

0.12

0.19

0.03

0.26

0.23

0.21

0.05

0.86

 C18:1 cis-14

1.00

0.81

0.10

0.36

0.63

0.50

0.11

0.57

 C20:1 trans-

0.84

0.90

0.03

0.36

0.52

0.64

0.11

0.64

 C22:1 n-9

0.16

0.09

0.03

0.22

0.38

0.60

0.09

0.23

 C24:1

0.14

0.71

0.11

< 0.01

1.44

1.92

0.14

0.10

Polyunsaturated FA

 C18:2 cis-12 trans-10 (CLA-t10)

0.17

0.66

0.15

0.18

0.51

0.56

0.10

0.82

 C18:2 cis-9 trans-11 (RA)

0.49

0.37

0.05

0.21

0.44

0.69

0.11

0.27

 C18:2 cis-9 cis-12 (LA)

6.42

8.07

0.40

0.02

15.1

17.6

0.93

0.19

 C18:3 cis-6 cis-9 cis-12

0.15

0.27

0.04

0.11

0.49

0.57

0.09

0.67

 C18:3 cis-9 cis-12 cis-15 (LNA)

1.47

2.28

0.16

< 0.01

1.05

1.73

0.19

0.05

 C20:2

0.43

0.37

0.06

0.63

0.35

0.44

0.10

0.68

 C20:3 n-6

0.63

0.65

0.07

0.89

4.04

5.11

0.38

0.17

 C20:4 n-6

nd.

nd.

nd.

nd.

0.51

0.42

0.05

0.44

 C20:5 n-3

nd.

nd.

nd.

nd.

0.74

0.64

0.14

0.73

 C22:2

0.08

0.16

0.04

0.28

0.62

0.49

0.15

0.72

 C22:5 n-3

nd.

nd.

nd.

nd.

0.64

0.90

0.09

0.17

 C22:6 n-3

nd.

nd.

nd.

nd.

0.45

0.79

0.15

0.27

∑ SFA

70.5

67.3

0.96

0.10

40.8

34.9

1.24

0.01

∑ UFA

29.5

32.7

0.96

0.10

59.2

65.1

1.24

0.01

∑ MUFA

18.7

20.1

0.60

0.66

34.3

35.1

0.95

0.70

∑ PUFA

10.8

12.5

0.51

< 0.01

24.9

30.0

1.01

0.07

∑ n-6

8.90

9.72

0.42

0.02

21.6

25.2

1.23

0.17

∑ n-3

1.47

2.28

0.16

< 0.01

2.88

4.06

0.31

0.07

n-6/n-3

6.05

4.37

0.39

0.02

7.86

6.74

0.73

0.47

PUFA/SFA

0.15

0.19

0.01

0.07

0.62

0.86

0.05

0.01

LNA/LA

0.21

0.30

0.02

0.02

0.07

0.10

0.01

0.31

∑ C18:1

15.7

16.8

0.64

0.45

27.4

26.8

1.22

0.81

∑ C18:1 trans-

5.48

5.08

0.28

0.52

1.37

0.96

0.11

0.06

∑ C18:1 cis-

10.2

11.7

0.58

0.23

26.1

25.8

1.19

0.94

∑ CLA

0.64

0.99

0.19

0.36

0.95

1.61

0.18

0.04

∑ MCFA

23.3

26.3

0.94

0.12

26.3

22.8

1.25

0.17

∑ LCFA

76.7

73.7

0.94

0.12

73.7

77.2

1.25

0.17

BH intermediates

7.81

7.76

0.46

0.95

nd.

nd.

nd.

nd.

LA BH, %

74.2

67.6

1.58

0.03

nd.

nd.

nd.

nd.

LNA BH, %

94.4

91.5

0.61

< 0.01

nd.

nd.

nd.

nd.

RA/VA

0.08

0.11

0.02

0.50

nd.

nd.

nd.

nd.

Desaturation index (DI) ∆9

nd.

nd.

nd.

nd.

0.41

0.47

0.01

0.01

D∆9. C14:1/C14:0

nd.

nd.

nd.

nd.

0.29

0.37

0.06

0.50

D∆9. 16:1/16:0

nd.

nd.

nd.

nd.

0.07

0.07

0.01

0.85

D∆9. 18:1/18:0

nd.

nd.

nd.

nd.

0.59

0.65

0.01

0.01

D∆9. RA/VA

nd.

nd.

nd.

nd.

0.27

0.48

0.06

0.04

D∆9. MUFA/SFA

nd.

nd.

nd.

nd.

0.46

0.50

0.01

0.08

D∆5. n-6. 20:4n-6/20:3n-6

nd.

nd.

nd.

nd.

0.12

0.08

0.01

0.11

D∆5. D6. n-6. 20:4n-6/18:3n-6

nd.

nd.

nd.

nd.

0.53

0.43

0.06

0.43

D∆4. n-3. 22:6n-3/22:5n-3

nd.

nd.

nd.

nd.

0.33

0.41

0.06

0.53

Elongase index

nd.

nd.

nd.

nd.

0.71

0.72

0.01

0.92

Thrombogenic index

nd.

nd.

nd.

nd.

0.85

0.62

0.05

< 0.01

Atherogenicity index

nd.

nd.

nd.

nd.

0.63

0.48

0.03

0.03

  1. CON control diet, CAL Coleus amboinicus Lour. diet, SEM standard error of means, SFA saturated fatty acids, UFA unsaturated fatty acids, MUFA monounsaturated fatty acids, PUFA polyunsaturated fatty acids, BH biohydrogenation, LNA linolenic acid, RA rumenic acid, VA vaccenic acid, LA linoleic acid, MCFA medium-chain fatty acids, LCFA long-chain fatty acids, nd. not determined
  2. Means in the same row indicate significant differences at P < 0.05 and tended to significant at P < 0.10